LSC Webinars CELL All

1. The Future Of Gene Therapy Production: Enriching Full Capsids, Reducing Costs 10/29/2025

   Explore how intensified upstream processing enriches full AAV capsids, reduces impurities, and lowers manufacturing costs. Learn how extended culture duration drives better outcomes.

2. Developing Your Risk-Based Approach To Single-Use System Integrity 10/29/2025

   Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.

3. Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes 10/28/2025

   Explore how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.

4. The Case For Optimized And Excipient GMP Cell Culture Solutions 10/27/2025

   Learn how optimized, customizable formulations and Excipient GMP manufacturing streamline development, ensuring quality and consistency for a de-risked path to the clinic.

5. Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches 10/22/2025

   Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.

6. Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation 10/22/2025

   Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.

7. In-Line PAT Solutions For cGMP Environments 10/21/2025

   Learn how real-time monitoring and PAT platforms can streamline bioprocessing, reduce testing delays, and improve decision-making across upstream and downstream workflows.

8. Development Of An Off-The-Shelf γδ T-Cell Platform 10/20/2025

   Learn how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.

9. From Plasmids To Cell-Free DNA Using Megabulb DNA 10/20/2025

   Discover a non-viral approach for T cell engineering that overcomes limitations of viral transduction. Learn how a novel single-stranded DNA template and CRISPR technology deliver a scalable solution.

10. Break The Cell Therapy Manufacturing Bottleneck With Day-0 Transduction, Day-3 Harvest 10/14/2025

    Discover the potential of T1 cell-derived nanoparticles (CDNPs) to accelerate T-cell activation. See how CDNPs’ unique mechanism of mimicking physiological immune stimulation positions them for broad use.